Abstract:AIM:To construct recombinant eukaryotic expression vectors pEGFP-C3-SNCA containing human wild-type (WT) and pathogenic mutations A30P, A53T alpha-synuclein (SNCA), and to obtain monoclonal PC12 cell lines overexpressing human wild-type and pathogenic mutations A30P, A53T alpha-synuclein by stable transfection.METHODS:Human wild type SNCA gene was cloned by using RT-PCR. By T-A extension cloning, the gene was ligated with T-vector and sequenced. Based on it, the recombinant eukaryotic expression vectors containing wild type SNCA synonymous mutation or its G88C (Ala30Pro) and G209A (Ala53Thr) pathogenic mutation were constructed by site-directed mutagensis using primer variance in mononucleotide. And different recombinant plasmids pEGFP-C3-SNCA were identified with PCR, restriction enzyme digestion and DNA sequencing. PC12 cells were transfected with different recombinant plasmids pEGFP-C3-SNCA by liposome transfection method, screened with G418, and subcloned by limited dilution method to obtain different monoclonal PC12 cell lines stably over-expressing human wild-type, A30P or A53T alpha-synuclein, respectively, and PC12 cells stably transfected with pEGFP-C3 were used as control group. These monoclonal PC12 cell lines were identified with RT-PCR, Western blot and fluorescence microscopy.RESULTS:According to result of PCR, the double digestion and gene sequencing, it was comfirmed that recombinant eukaryotic expression vectors containing wild type SNCA synonymous mutation or its Ala30Pro and Ala53Thr pathogenic mutation had been constructed successfully. By means of RT-PCR, Western blot and fluorescence microscope, it was comfirmed that objective gene sequences in PC12 cells were stably over-expressed.CONCLUSION:The recombinant pEGFP-C3-SNCA vectors containing wild type SNCA synonymous mutation or its Ala30Pro and Ala53Thr pathogenic mutations had been constructed successfully. The transfected monoclonal PC12 cells are obtained in which three SNCA gene isoforms had stable expression.

Construction and identification of eukaryotic expression vector for mutant PCNA

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Application of Homologous Recombination in Vitro to Construct Pcdna3.1-Ngf and Pcdna3.1-Trka

Construction and Expression of Eukaryotic Expression Vector for I Kappa B Alpha Mutant Gene

Construction of an eukaryotic expression vector inserted human IκBα mutant gene

Construction and Identification of Five Mutants of Hil-18 in Expression Plasmid and Their Expression in BxPC-3 Cells

Construction of Eukaryotic Expression Plasmids Containing Green Fluorescent Protein Gene and CYP19 WT or Its Variants

Construction and expression of mutate plasmid CMV-3flag-hPROKR2(343YFK/AAA345,351 HWR/AAA353)

[Construction of Eukaryotic Expression Vector Containing Hsnca Gene and Its Pathogenic Mutants and Its Expression in PC12 Cells].

Construction of expression plasmid of the mutant PUMA and its expression in Hela cells

Construction and Expression of Mutant TRBP Gene

Construction and identification of fusion gene of NT4-p53(N37)-HA2-TAT

Construction and Identification of Human PRMT1 Gene Eukaryotic Vector

Construction, Expression and Purification of Wild and Mutant Type of Nm23-H1 in Prokaryotic Expression System

Construction of SCN3A gene mutant expression vector andits expression in HEK 293 cells

Construction and Identification of Vectors Encoding Both Wide Type P53 Protein and Sirna-Vegf on PC-3 Cells

Construction and identification of recombinant eukaryotic expression vector of human anti-sense cortical actin- associated protein gene

Construction and characterization of human SUMO3 mutant (SUMO3-K11R) eukaryotic expression vector

Study on the Molecular Pathogenesis Underlying a Novel Protein C Mutation

Construction of eukaryotic expression vector of E4F1 and interactions between E4F1 and p53

Construction and identification of fusion gene of NT4-p53(N15)-Ant